D Snook
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 14
- Radiopharmaceutical Chemistry and Applications 11
- Oncology 8
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 3
- Co-authors
- G. Hooker (8 shared papers)A. A. Epenetos (8 shared papers)Vicky Hird (6 shared papers)Gregory B. Sivolapenko (6 shared papers)Claude F. Meares (4 shared papers)B Dhokia (5 shared papers)Nigel S. Courtenay-Luck (4 shared papers)Agamemnon A. Epenetos (5 shared papers)
- Journals
- British Journal of Cancer (3 papers)The Lancet (2 papers)The International Journal of Biological Markers (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomGreeceUnited States
In The Last Decade
D Snook
21 papers receiving 875 citations
Peers
Comparison fields: 5 of 67
- Radiology, Nuclear Medicine and Imaging 736
- Reproductive Medicine 102
- Oncology 212
- Pathology and Forensic Medicine 129
- Immunology 129
Countries citing papers authored by D Snook
This map shows the geographic impact of D Snook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Snook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Snook more than expected).
Fields of papers citing papers by D Snook
This network shows the impact of papers produced by D Snook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Snook. The network helps show where D Snook may publish in the future.
Co-authors
The 25 scholars most cited alongside D Snook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 144 | |
| 2 | Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. | 1990 | 122 |
| 3 | 1990 | 109 | |
| 4 | 1989 | 99 | |
| 5 | Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. | 1992 | 77 |
| 6 | 1985 | 69 | |
| 7 | Macrocyclic chelates of radiometals for diagnosis and therapy. | 1990 | 54 |
| 8 | Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund. | 1984 | 54 |
| 9 | 1986 | 49 | |
| 10 | 1991 | 35 | |
| 11 | Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments. | 1988 | 34 |
| 12 | Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies. | 1988 | 29 |
| 13 | Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions. | 1990 | 27 |
| 14 | Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy. | 1995 | 18 |
| 15 | 1994 | 10 | |
| 16 | 1986 | 8 | |
| 17 | 1990 | 6 | |
| 18 | Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase. | 1991 | 3 |
| 19 | Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med | 1990 | 2 |
| 20 | 1988 | 2 |
About D Snook
D Snook is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Biotechnology, having authored 21 papers that have together received 952 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (11 papers), HER2/EGFR in Cancer Research (5 papers), Medical Imaging and Pathology Studies (4 papers), Peptidase Inhibition and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Research and Treatments (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (736 citations), Reproductive Medicine (102 citations), Oncology (212 citations), Pathology and Forensic Medicine (129 citations) and Immunology (129 citations). D Snook has collaborated with scholars based in United Kingdom, Greece and United States. Frequent co-authors include G. Hooker, A. A. Epenetos, Vicky Hird, Gregory B. Sivolapenko, Claude F. Meares, B Dhokia, Nigel S. Courtenay-Luck, Agamemnon A. Epenetos, Hannah E. Lambert and Haralabos P. Kalofonos. Their work appears in journals such as British Journal of Cancer, The Lancet, The International Journal of Biological Markers, International Journal of Radiation Oncology*Biology*Physics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.